Home › Congenital Adrenal Hyperplasia › Michigan
Congenital Adrenal Hyperplasia clinical trials in Michigan
4 studies for Congenital Adrenal Hyperplasia are looking for participants at sites in Michigan.
Cities in Michigan
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
- University of Michigan, Ann Arbor
RecruitingPhase 2/3
Ages 1 to 17 · All sexes · Updated Sep 30, 2026 · NCT07159841A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
- Crinetics Study Site, Ann Arbor
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 30, 2026 · NCT07144163Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
- Neurocrine Clinical Site, Ann Arbor
RecruitingPhase 2
3 Months – 47 Months · All sexes · Updated Sep 16, 2026 · NCT07536269A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
- University Hospital-University of Michigan, Ann Arbor
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Mar 9, 2026 · NCT05669950From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.